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OBJECTIVES This study was designed to evaluate the characteristics of gadolinium-enhanced imaging of
radiofrequency ablations.
BACKGROUND Gadolinium-enhanced magnetic resonance imaging (MRI) has been used successfully to
evaluate tissue necrosis after myocardial infarction. In electrophysiology, radiofrequency
energy is used to create a targeted myocardial necrosis for the treatment of various
arrhythmias.
METHODS Using a power-controlled, cooled-tip 7-F catheter system, radiofrequency lesions (10 to 40W for
30 s) were created on the epicardium of the right ventricle in eight mongrel dogs. After injection
of 0.225 mmol/kg gadolinium, T1-weighted fast gradient echo images were obtained during a
follow-up of 10 h using an intrathoracic high-resolution coil. Radiofrequency ablations were
analyzed on the MR images and compared with gross anatomy and histopathology.
RESULTS Four distinct phases of signal enhancement were observed. After gadolinium injection,
radiofrequency lesions were delineated clearly as contrast-free areas of low signal intensity
(contrast-to-noise ratio [CNR]  21.1  19.8). Signal enhancement in the lesion
periphery started 4.0  1.8 min after injection and progressively extended toward the lesion
center at a rate of 0.02 mm/min. Full delayed enhancement was observed after 98  21 min
(CNR  17.8  9.0). During the follow-up period, CNR started to decrease, but the
lesions were detectable for as long as 10 h of follow-up. During the first three phases of
enhancement, MRI correlated well with the pathological findings (r  0.88, r  0.88, and
r  0.86 [p  0.001], respectively).
CONCLUSIONS Radiofrequency ablation can be evaluated accurately by using gadolinium-enhanced MRI,
which may allow the noninvasive assessment of procedural success. The dissimilar wash-in
and wash-out kinetics compared with myocardial infarction suggest a different pathophysi-
ological process with complete loss of microvasculature. (J Am Coll Cardiol 2006;47:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.07.070370–8) © 2006 by the American College of Cardiology Foundation
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Aadiofrequency ablation (RFA) allows the catheter-based
reation of well-defined, limited myocardial necrosis and
as significantly changed the treatment of arrhythmias since
ts introduction to electrophysiology (1). However, newer
blation strategies increasingly rely on anatomic rather than
lectrophysiological approaches (2,3), which makes the
isualization of the lesions with respect to their extent and
natomic location increasingly important. Yet, the current
atheter guiding techniques mostly rely on fluoroscopy and
hree-dimensional mapping devices, which are limited in
heir ability to confirm the presence, exact location, and
xtent of ablation lesions, parameters that serve as indicators
f the procedural success (3,4).
This anatomic information could potentially be provided
y gadolinium-enhanced magnetic resonance imaging
MRI), as it has been shown to reliably visualize necrotic
issue (after myocardial infarction) with a reproducible
nhancement pattern (5). First-pass images performed im-
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005, accepted July 26, 2005.ediately after a gadolinium injection frequently demon-
trates areas of hypoenhancement in the endocardial core of
he infarct (6,7), followed by complete delayed enhance-
ent of the myocardial necrosis 5 to 25 min after contrast
njection with a subsequent wash-out period (6,8).
Correspondingly, MRI can detect the heat-related
hanges of T1 and T2 parameters in the necrotic myocar-
ium after RFA and is able to confirm the existence of
FAs in the very acute setting (9). However, many clinical
elevant questions, such as the characterization of radiofre-
uency lesions during the different stages of enhancement,
he effect of radiofrequency energy on lesion visualization,
nd the ability to assess anatomic correlates to ablation
uccess such as transmural extent and lesion gaps, will have
o be clarified before this technology can be applied for
rolonged and frequently complicated clinical procedures.
herefore, this study sought to systematically evaluate the
haracteristics of MRI for radiofrequency lesions.
ETHODS
nimal preparation. Eight mongrel dogs weighting 30 to
5 kg were premedicated with 10 mg of ketamine intramus-
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January 17, 2006:370–8 Characterization of Ablations Lesions With MRIularly and maintained on 80% oxygen and 1.5% isoflurane
as using a Narkomed Anesthesia ventilator (Draegar,
elford, Pennsylvania). Surface electrocardiogram leads I,
I, and III were monitored continuously. Using the cutdown
echnique, an 8-F introducer sheath was placed in the right
ugular vein for the administration of fluids and medication.
sing clinical-grade surgical equipment, a thoracotomy was
erformed in the midsternal line and the pericardium
emoved. Using a standard 7-F ablation catheter with a
-mm electrode single, radiofrequency lesions were created
n the epicardial surface of the right ventricle with a
linical-grade radiofrequency generator (Atakr, Medtronic,
inneapolis, Minnesota) while the ablation site was con-
tantly irrigated with 0.9% normal saline (21° C) at a rate of
ml/min. Ablation lesions were created in a linear inter-
upted fashion using a power-controlled mode at 10, 20, 30,
nd 40 W for 30 s each. After the ablation, the animals were
onitored hemodynamically for 10 min, surgical tools and
aramagnetic materials were removed, and the live animals
ere transported immediately with an unclosed chest prep-
ration to the MRI suite. All animal protocols were re-
iewed and approved by the Animal Care and Use Com-
ittee at the Johns Hopkins University and conformed to
he guidelines published in the “Position of the American
eart Association on Research Animal Use.”
maging protocol. The animal was placed in a 1.5-T MR
canner (Signa XL, GE, Waukesha, Wisconsin). Using a
-inch high-resolution coil, which was placed intrathoraci-
ally on the right ventricle, the correct imaging plane of the
blation lesions was identified with standard T1- and
2-weighted scout images. Magnevist (0.225 mmol/kg;
adopentetate dimeglumine, Berlex, Monteville, New Jer-
ey) was injected intravenously. Continuous long-axis im-
ges were obtained throughout the area of RFA with a
-mm slice thickness every 5 to 15min during the first 3 h
nd every 30 to 60 min up to a duration of 15 h using a
1-weighted, inversion prepared fast gradient recall echo
equence (TR  3.6 ms, TE  1.7 ms, TIadjusted  175 to
75 ms [to “null” normal myocardium], field of view  18
m, flip angle  20°, readout bandwidth  32 kHz, matrix
56  192, number of signal averages (NEX) 1, slice
hickness  3 mm). All images were visually inspected to
ule out the presence of susceptibility artifacts caused by the
ir-tissue interface of the open chest preparation. Animals
Abbreviations and Acronyms
ANOVA  analysis of variance
CNR  contrast-to-noise ratio
GEE  generalized estimating equation
MRI  magnetic resonance imaging
RFA  radiofrequency ablation
SI  signal intensity
SNR  signal-to-noise ratioere monitored and alive during all imaging sequences. mostmortem examination. Immediately after the imaging
rotocol, the animals were injected with 20 ml of a 20%
olution of 2,3,5-triphenyltetrazolium chloride and sacri-
ced with an intravenous injection of high-molar potassium
hloride solution. The hearts were excised, fixated, and
ectioned through the right ventricular lesion corresponding
o the tomographic MRI slices. Lesion location, morphol-
gy, width, length, and transmural extent were determined
nd recorded at gross examination and photographed for
ater comparison with the MR images. Sections from
hermally damaged tissues were submitted for histological
taining (Masson’s trichome and hematoxylin-eosin) and
nalyzed under light microscopy to characterize global
orphological changes.
ata analysis. Lesion character and signal intensity (SI)
ere measured directly from MR images and analyzed with
n off-line quantitative analysis package (version 1.53;
-film, Merge Technology, Milwaukee, Wisconsin). Lesion
ize was determined as the maximal lesion diameter at the
uter margin of the contrast void (Phase 1) or the enhanced
esion (Phase 2 to 4).
Signal-to-noise ratio (SNR) was measured as the SI of
he lesion over the standard deviation (SD) of the back-
round noise. Contrast-to-noise ratio (CNR) was deter-
ined as the SI of lesion minus the SI of the adjacent
yocardium, which was then divided by the SD of the
ackground noise. Lesion parameters at gross examination
ere measured independently of magnetic resonance images
nd compared.
tatistical analysis. Changes in lesion size and SI were
nalyzed during the time-course and between the various
nergy groups and were considered significant at a level of p
0.05 in a paired t-test (analysis of variance [ANOVA]).
omparisons of ablation lesions in MRI and in pathological
pecimen was performed by a native analysis using linear
egression and additionally by an adjusted analysis using a
eneralized estimating equation approach (GEE) to control
or a potential cluster effect. Unless noted otherwise, results
easurements are reported as arithmetic mean  SD. We
onsidered p values at a level of 0.05 as statistically
ignificant.
ESULTS
ime course of radiofrequency lesion enhancement. In-
ependent of the radiofrequency energy and the size of the
blation lesion, all radiofrequency lesions could be visualized
fter enhancement using gadolinium. We injected the
adolinium 2.1  0.6 h after the creation of the radiofre-
uency lesions.
In all experiments, four characteristic phases of enhance-
ent were observed after the administration of gadolinium.
n the first phase immediately after injection, radiofre-
uency lesions were visible as areas of contrast void (Figs.
A and 1B) in comparison with the enhanced, nonablated
yocardium (CNR  21.1  19.8) (Fig. 2A) and blood
p
3
5
w
s
r
(
0
b
s
i
i
m
G
P
t
F
d

c
d
a
372 Dickfeld et al. JACC Vol. 47, No. 2, 2006
Characterization of Ablations Lesions With MRI January 17, 2006:370–8ool (CNR  49.8  38.7). Measured SNRs were 8.1 
.9 vs. 29.3  17.1 (p  0.01) (Fig. 2B) and 8.1  3.9 vs.
9.1  43.2 (p  0.01), respectively. Lesion size by MRI
as 7.8  2.8 mm compared with in the pathological
pecimen 6.4 2.7 mm (p 0.05 for difference). Magnetic
esonance imaging correlated well with pathological results
r 0.88, p 0.001; GEE: regression coefficient 0.87, p
.0001) (Fig. 3A) and slightly overestimated the lesion size
igure 1. Gadolinium enhancement of a radiofrequency ablation lesion.
emonstrates four characteristic phases of enhancement: (A) Schematic of
30- and 40-W RF ablation lesions; Myo  right ventricular myocardial
avity). (B) Phase 1 with a contrast void. (C and D) Phase 2 displaying an
elayed enhancement with high signal intensity throughout the ablation les
nd lesion size. (G) Corresponding pathological specimen.y 1.4  1.7 mm. 3In the second phase, a high SI enhancement was observed
tarting from the lesion periphery 4.0  1.8 min after
njection (Figs. 1C and 1D). This ring-like enhancement
ncreased in thickness at a rate of approximately 0.02
m/min toward the lesion center (r  0.88, p  0.001;
EE correlation coefficient 0.78, p  0.0001) (Fig. 3D).
eripheral hyperenhancement was well delineated against
he nonenhanced lesion center (CNR  11.5  3.3; SNR
ime-course (1 to 600 min) after injection of 0.225 mmol/kg gadolinium
netic resonance (MR) images (30-W radiofrequency [RF] and 40-W RF
EP  epicardial side; EN  endocardial side; RV-C  right ventricular
asing peripheral enhancement (white arrows). (E) Phase 3 showing “very”
F) Phase 4 displaying loss of enhancement with decreasing signal intensityThe t
mag
wall;
incre
ion. (0.2  14.6 vs. 18.7  13.4; p  0.001) and the surround-
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January 17, 2006:370–8 Characterization of Ablations Lesions With MRIng myocardium (CNR  18.0  11.7; SNR 30.2  14.6
s. 12.2  11.3; p  0.001) as shown (Figs. 2A and 2B).
esion size did not differ significantly from measurement of
he contrast void (Phase 1; 7.7 2.6 mm vs. 7.8 2.8 mm;
NOVA: p  0.05) and correlated well with the patholog-
cal measurements (r  0.88, p  0.001; GEE regression
oefficient 0.89, p  0.0001) (Fig. 3B). Magnetic resonance
maging overestimated the lesion size by 1.3  1.9 mm,
hich was not significantly different from the magnetic
esonance measurements in Phase 1.
During the third phase, the complete lesions showed
omogenous gadolinium enhancement (Fig. 1E). Time to
omplete enhancement was longer with larger lesion size
nd occurred in average after 98  21 min (Fig. 3D). The
esion was easily detected as a result of a CNR of 17.8 9.0
SNR 24.1 10.3 vs. 6.3 2.1; p 0.0001) (Figs. 2A and
B) and correlated well with the pathological specimen (r
.86, p  0.001; GEE regression coefficient 0.85, p 
.0001) (Fig. 3C). The lesion size by MRI was 8.0 
igure 2. Contrast-to-noise-ratio during the four phases of gadolinium-
nhanced imaging between the radiofrequency lesion and the adjacent
yocardium (A). Signal-to-noise ratio of radiofrequency lesions during the
our phases of gadolinium enhancement in lesion center, lesion periphery,
nd adjacent myocardium (B)..0mm, which was not different from the lesion size Istimated during the Phase 1 or 2. The magnetic resonance
mage overestimated the pathological lesion size by 1.6 
.1mm, which was not statistically significant from Phase 1
r 2 (ANOVA).
During further follow-up, the imaged lesion size started
o decrease from the periphery (Phase 4), which was
atched by a beginning decrease in overall SI (Fig. 1F).
fter 288  33 min, the CNR was 15.6  6.2 (SNR 20.0
6.5 vs. 4.4  1.5; p  0.001), which allowed the lesions
o remain visible for the complete follow-up of up to 10 h
Figs. 2A and 2B). As expected, the lesion size increased
ith the amount of ablation energy (p  0.05), but the
esion-enhancement pattern and the overall signal intensi-
ies were independent of the radiofrequency energy applied
p  0.05 by ANOVA).
ssessment of transmural extent and lesion gaps. Trans-
ural extent was assessed during the first phase of a contrast
oid as well as during the third phase of complete enhance-
ent in 25 radiofrequency lesions with an average depth of
.9 1.8 mm (range, 2.0 to 10.6 mm corresponding to 26%
o 100% of the ventricular wall thickness). Seven of the 25
esions were transmural. Assessment of the transmural
xtension by MRI correlated well with the pathological
pecimen (r  0.87 and r  0.85, respectively, p  0.01 for
oth; GEE regression coefficient 0.83 and 0.73, p  0.0001
or both) and did not show a significant difference when
nalyzed for increasing degrees of transmural extent (26% to
9%, 50% to 75%, or 76% to 100%, respectively). Measure-
ents during the phase of contrast void overestimated the
ransmural extent by 1.1  1.3 mm and classified three
ontransmural lesions incorrectly (sensitivity: 100%, speci-
city: 83%). During “very” delayed enhancement, the le-
ions appeared 1.7  1.5 mm larger. One lesion was
ncorrectly classified as transmural and one as nontransmu-
al (sensitivity: 86%, specificity: 95%).
Twenty-one discontinuous lesions (“gaps”) with an aver-
ge size of 6.0  4.7 mm [range, 0 mm to 23.9 mm] were
imilarly assessed during the early phase of contrast void and
he delayed phase of complete gadolinium enhancement
Figs. 2 and 4). Early (contrast-void) and late (complete
nhancement) images after gadolinium injection allowed
xcellent delineation of the radiofrequency gaps with a
NR of 21.2  19.6 and 17.9  10.2, respectively (p 
.001). The gap size was correlated well with the patholog-
cal measurements (r  0.86 for both; p  0.01, GEE
egression coefficient 0.77 and 0.80, p  0.0001 for both)
nd underestimated the gap by 1.3 1.1 mm and 0.8 1.2
m during contrast void and complete enhancement,
espectively.
istopathology. Radiofrequency lesions were character-
zed by a core of severe coagulation necrosis with complete
oss of cellular and vascular architecture, which covered
80% of the total lesion area. In the lesion periphery, a rim
f contraction band necrosis was observed with partially
ntact myocardial cells and areas of intralesional hematoma.
ntact vascular structures obstructed with neutrophiles,
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Characterization of Ablations Lesions With MRI January 17, 2006:370–8rythrocytes, and cellular fragments were observed. This
rea was surrounded by a perilesional rim of intact myocar-
ial cells exhibiting edema with occasional intralesional
emorrhage, but mostly intact vasculature (Fig. 5).
ISCUSSION
ain findings. The main findings of this study are: 1)
adolinium-enhanced MRI of radiofrequency lesions dis-
lays four distinct phases of enhancement: signal void,
eripheral enhancement, “very” delayed complete enhance-
ent, and loss of enhancement; 2) radiofrequency lesions
ize, transmural extent, and interlesional gap can be ade-
uately assessed throughout the different stages of gadolin-
um enhancement; 3) MRI appearance of radiofrequency
esions is similar over a wide range of applied energy; and 4)
ash-in kinetics are different from myocardial infarction
nd may suggest a diffusion process.
adolinium enhancement of myocardial necrosis. Ra-
igure 3. Correlation of radiofrequency lesion size and peripheral enhance
ith the lesion size assessed by magnetic resonance imaging (MRI) during
hase 3 of “very” delayed enhancement (C). Increasing thickness of periphe
center of low signal after the injection of 0.225 mmol/kg of gadoliniumiofrequency lesions of all energy levels were visible after tadolinium injection as a signal void. A lack of enhance-
ent in the endocardial core has been described in acute
yocardial infarction during the first transit of the gadolin-
um in only about 50% of ischemically injured segments (10)
nd is thought to represent occlusion of microvasculature
ith erythrocytes, neutrophils and cellular debris, which is
lso known as “no-reflow” phenomenon (6,7). However, all
hese segments displayed some gadolinium enhancement
fter about 7 min, corresponding to the near-equilibrium
pseudoequilibrium) phase with complete enhancement af-
er about 20 min (10). Similarly, in patients undergoing
thanol-induced septal ablation for hypertrophic obstructive
ardiomyopathy complete delayed enhancement could be
emonstrated after 20 min (11). Differently, in RF lesions,
he contrast void was a predominant characteristic after
adolinium injection in all lesions and was not replaced by
omplete enhancement until about 1.5 h after gadolinium
as administered. This observation might be explained by
. Shown is the lesion size assessed in the pathological specimen compared
hase 1 of contrast void (A), Phase 2 of peripheral enhancement (B), and
hancement over time observed as a rim of high signal intensity surroundingment
the Phe histology of the RF lesions, which showed severe
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January 17, 2006:370–8 Characterization of Ablations Lesions With MRIoagulation and contraction band necrosis with complete
oss of cellular and vascular architecture up to a small
ransition zone at the periphery (12). Thus, RF lesions may
xhibit an extreme and irreversible “no-reflow” phenome-
on, responsible for the different wash-in kinetics observed.
These histological findings also may explain the second
hase of a slowly progressive, ring-like, peripheral enhance-
ent of RF lesions, which is different from infarcted
yocardial tissue. Gadolinium with a molecular weight of
pproximately 800 Daltons is thought to be biologically
nert and to passively diffuse throughout the extracellular
pace (13). Although after myocardial infarction reperfusion
r collateral blood supply achieves complete delayed hyper-
nhancement after 10 min (6–8), enhancement of the
evascularized RF lesion seems to rely mostly on diffusion
rom the lesion periphery. Because the diffusion time
ncreases with the distance the lack of functional capillaries
ight explain the prolonged time course when compared
ith infarcted myocardium (14).
Thus, we suggest the term “very delayed enhancement” to
escribe the prolonged time course of RF lesion enhance-
ent compared with the observations in myocardial infarc-
ion that occurs significantly earlier (5,6). Increase in volume
f distribution and regional differences in wash-in/wash-out
ime constants have been proposed as possible mechanisms
f hyperenhancement in infarcted tissue (5,15–17). An
ccumulation of gadolinium within the area of hyperen-
igure 4. Evaluation of discontinuous ablation line. Gap (dotted arrow) ob
pecimen after chloraldehyde preparation (left panel) and with gadoliniumancement was recently shown by Rehwald et al. (17), who semonstrated an increased gadolinium concentration of 235
24% in acute infarct and of 472  78% in chronic infarct
easured directly with electron probe x-ray microanalysis.
n the other hand, Kim et al. (5) were able to show that in
3 rabbits the differences in regional enhancement were
ostly due to changes in regional microsphere-determined
ow.
In our experiments, gadolinium imaging slightly overes-
imated the pathological lesion size (and therefore underes-
imated the gap size) during the different phases of delayed
nhancement. Similarly, several MR studies overestimated
he size of myocardial infarction by 10% to 20%, which was
ontributed to an increased accumulation in the border zone
7,16,18,19). However, detailed ex vivo studies using ultra-
hin MRI (500 m) have demonstrated a good correlation
f delayed hyperenhancement with the area of myocardial
ecrosis (8). Additionally, direct measurements of gadolin-
um in the adjacent myocardium of risk that failed to show
significant increase in gadolinium contents (17). There-
ore, overestimation in lesion size of myocardial infarction
nd RF lesions is possibly the result of partial-volume effects
aused by slice thickness requirements inherent to in vivo
maging (8).
During further follow-up, the peripheral enhancement of
he RF lesions was increasingly lost (“shrinking lesion”) as
ell as the overall signal decreased (“less bright lesion”).
owever, lesions remained visible for up to 10 h. Wash-out
in ablation line between two ablation lesions (solid arrows). Pathological
anced magnetic resonance imaging (right panel).tudies in myocardial infarction similarly described a periph-
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Characterization of Ablations Lesions With MRI January 17, 2006:370–8ral decrease in enhancement. However, a significant loss of
yperenhanced regions except for centrally located patches
as been described as early as 25 min after gadolinium
njection (5). The differences in the time course can likely be
ttributed to the histologic changes in RF lesions, resulting
n a slower diffusion-only process out of the ablated area.
adolinium enhancement of RFAs. Experiences with
adolinium-enhanced imaging of RF lesions have been
ery limited. In the only animal study Lardo et al. (9)
eported a 12 min follow-up of RF lesions in the right
entricle of six mongrel dogs. He described hyperen-
ancement of the lesions after 1 min with an SI of 1.55
0.16 times the preinjection values and gradual signal
ecrease during the 11 min of follow-up. These data
iffer from our observations and might be the result of a
artial-volume effect and a difference in resolution. Al-
hough our study used a high-resolution coil with a slice
hickness of 3 mm for an RF lesions size of 6.4  2.7
m, Lardo et al. (9) used a cardiac phase array with a
lice thickness of 7 mm for an average lesion of only 3.4
2.1 mm. This may have prohibited a more detailed
valuation of regional differences within the lesion. Ad-
itionally, a smaller lesion size may have facilitated a
igure 5. Radiofrequency ablation lesion. Masson’s trichrome stain. (A) A
and necrosis. (B) Blue center core with severe coagulation necrosis, necr
emonstrating contraction band necrosis with erythrocytes and cell debris
n millimeters (mm).ore rapid diffusion of gadolinium into the lesion. cThe only other report is a case study showing delayed
nhancement in an area of previous RFA for idiopathic left
entricular tachycardia in an 45-year-old patient (20).
Although our findings differ substantially from the ob-
ervations in gadolinium-enhancement after myocardial in-
arction several similarities can be found with MRI of RFA
n noncardiac tissue. After RFA of prostate cancer in 10
atients, lesions appeared as hypointense foci immediately
fter gadolinium injection (21). After ablation of liver
etastasis, Goldberg and Dupuy described a lack of en-
ancement immediately after gadolinium injection, but a
im-like enhancement in delayed images (22). In multiple
nimal studies, RF lesions in liver, lung, brain, and pancreas
isplayed a characteristic pattern of nonenhancing center
ith peripheral rim enhancement (23–26). Lesion size
orrelated well with the pathological specimen (r  0.91 to
.93) (23) and overestimated the lesion size by 0.8  1.2
m (23) to 2.2  1.0 mm (27), which may suggest that the
istology changes rather than the type of tissue determine
he MRI characteristics.
tudy limitations. Several limitations have to be consid-
red related to this study. Although most of the clinical RF
esions are created endocardially, epicardial lesions were
adjacent myocardium; CAN  coagulation necrosis; CBN  contraction
avity, and complete loss of cellular structure. (C) Light purple periphery
culature. (D) Adjacent viable myocardium. Calibration bars are presentedM 
otic chosen in this study to allow controlled lesion creation and
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January 17, 2006:370–8 Characterization of Ablations Lesions With MRIuarantee lesion creation over a wide variety of energy as its
valuation was on of the goals of the study. While the
acroscopic and histological appearance of the ablation
esions in our study was similar to those described for
ndocardial ablations (12), we cannot rule out a possible
ffect on imaging characteristics.
Gadolinium injection and MRI was performed 2.1 
.6 h after RFA. In our study, this was due to the transfer
ime and the necessary setup in the MRI scanner. However,
linical procedure times for complicated ablations frequently
re several hours; thus, if MRI is used for postprocedural
ssessment, an RF lesion age of 2 h is realistic.
Histological changes occurring during the days and
eeks after ablation (12) and may influence the wash-in
nd wash-out kinetics. In our experiments, no differences
n the enhancement pattern were observed between
ifferent experiments, nor did other RF studies of longer
ollow-up (24). However, future studies will have to
ddress this issue.
linical implications. Recent advances in ablation strat-
gies advocate an anatomic rather than electrophysiolog-
cal approach toward ablation of, e.g., isthmus-dependent
utter, atrial fibrillation, and nonidiopathic ventricular
achycardia (2,3). Although current catheter guiding
echniques have only a limited ability to demonstrate the
ocation and size of an ablation lesion, gadolinium-
nhanced MRI could assess the ablation results after
omplex RFA and potentially provide an end point for
hese anatomically guided procedures. In interventional
RI/fluoroscopy units, MR images could be used to
ssess incremental progress during the procedure. The
ew generation of electrophysiologic mapping systems
ith image integration capability could provide images of
ailed ablations (e.g., gaps in ablation lines) and direct
epeat procedures. Finally, with a potential real-time
RI system continuous information about the cardiac
natomy and the ablation lesions could be obtained.
This study showed that some significant differences exist
etween the pattern of delayed enhancement of necrotic
issue in myocardial infarction and after radiofrequency
blation. However, the knowledge about these dissimilari-
ies may allow—as in this study—to reliably evaluate the
blation lesions throughout the different phases of enhance-
ent. Additional studies are now warranted to further
efine its clinical applicability in electrophysiology and
ossibly open another application of MRI in the field of
ardiology.
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